Atopic Dermatitis
Clinical Trial

Do you have atopic dermatitis?

What is Atopic Dermatitis?

Atopic Dermatitis (AD) is a inflammatory skin disease affecting approximately 10% of adults worldwide, with cases on the rise. While treatments for AD have improved in recent years, researchers are committed to further advancing therapies for people with mild to severe AD through clinical trails.

Qualified Patients Should:

  • Are 18 years of age or older
  • Diagnosed with moderate to severe Atopic Dermatitis 
  • Cannot use or have not responded will to topical corticosteroids
  • Available for 10 month study period


  • Study-related physical exam & procedures at no cost
  • Study Medication
  • Compensation for time & travel

What to expect

Study participation provides a chance to recieve new or previously unavailable procedures, at no cost. 

Throughout the study you will be closely evaluated to ensure that the treatment received meet the highest scientific and medical standards. 

3A’s researchers and staff have been carefully selected for their certifications and ability to preform study related procedures and exceptional patient care. 

Participating in a clinical study is always voluntary (your choice). You can stop taking part in the study at any time without consequences to your usual medical care. 

Sign Up
for a
3A Study!

Complete the form below to begin the sign up process.